1-165205915-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 6P and 4B. PVS1_StrongPP5_ModerateBS2
The NM_177398.4(LMX1A):c.937C>T(p.Arg313Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000109 in 1,461,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
LMX1A
NM_177398.4 stop_gained
NM_177398.4 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 9.34
Genes affected
LMX1A (HGNC:6653): (LIM homeobox transcription factor 1 alpha) This gene encodes a homeodomain and LIM-domain containing protein. The encoded protein is a transcription factor that acts as a positive regulator of insulin gene transcription. This gene also plays a role in the development of dopamine producing neurons during embryogenesis. Mutations in this gene are associated with an increased risk of developing Parkinson's disease. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.185 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PP5
Variant 1-165205915-G-A is Pathogenic according to our data. Variant chr1-165205915-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 2503455.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 16 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LMX1A | NM_177398.4 | c.937C>T | p.Arg313Ter | stop_gained | 8/9 | ENST00000342310.7 | |
LMX1A-AS2 | XR_922234.2 | n.366+145G>A | intron_variant, non_coding_transcript_variant | ||||
LMX1A | NM_001174069.2 | c.937C>T | p.Arg313Ter | stop_gained | 8/9 | ||
LMX1A | XM_011509538.4 | c.697C>T | p.Arg233Ter | stop_gained | 6/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LMX1A | ENST00000342310.7 | c.937C>T | p.Arg313Ter | stop_gained | 8/9 | 2 | NM_177398.4 | P1 | |
LMX1A | ENST00000367893.4 | c.937C>T | p.Arg313Ter | stop_gained | 7/8 | 1 | P1 | ||
LMX1A | ENST00000489443.2 | n.571C>T | non_coding_transcript_exon_variant | 6/7 | 1 | ||||
LMX1A | ENST00000294816.6 | c.937C>T | p.Arg313Ter | stop_gained | 8/9 | 2 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251412Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135866
GnomAD3 exomes
AF:
AC:
5
AN:
251412
Hom.:
AF XY:
AC XY:
2
AN XY:
135866
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461844Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727228
GnomAD4 exome
AF:
AC:
16
AN:
1461844
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
727228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Autosomal dominant nonsyndromic hearing loss 7 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Department of Human Genetics, Hannover Medical School | May 31, 2023 | This alteration leads to a premature stop signal, most likely resulting in degradation of the formed mRNA via nonsense-mediated mRNA decay (NMD) and/or expression of a truncated protein. The population database gnomAD reports an allele frequency of 0.002% for the variant (gnomAD; ALL). Literature data are currently not available. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
D;D;D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at